More importantly, based on the above tumor-cell-intrinsic mechanism of immunotherapy resistance, high expression of MTDH may theoretically associate with poor immunotherapy response due to its regulations on PI3K, MAPK, and WNT pathways. Here, MTDH is linked to neoplasm.